Frances R. Frankenburg, MD

Symptomatic Remission and Overall Recovery From BPD

October 23, 2024

Over 24 years, patients with BPD were significantly slower to achieve remission or recovery than patients with other personality disorders. Ultimately, however, both groups achieved similarly high rates of...

Mary C. Zanarini, Frances R. Frankenburg, Katherine E. Hein, et al

Original Research

Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time

August 7, 2024

Findings suggest that the absence of substance use disorders is the strongest predictor of achieving recovery from BPD.

Mary C. Zanarini, Frances R. Frankenburg, Isabel V. Glass, et al

Original Research

Smoking in Borderline Patients

November 8, 2023

This study assessed predictors of smoking in borderline personality disorder and compared smoking prevalence in recovered vs non-recovered patients.

Marcelo J. A. A. Brañas, Frances R. Frankenburg, Christina M. Temes, et al

Original Research

Deaths in Borderline Personality Disorder Patients

January 22, 2019

Borderline personality disorder (BPD) is associated with increased suicidality, but less is known about other forms of premature death in individuals with BPD. Read this article to learn how...

Christina M. Temes, Frances R. Frankenburg, Garrett M. Fitzmaurice, et al

Original Research

The Use of Prescription Opioid Medication by Patients With Borderline Personality Disorder and Axis II Comparison Subjects: A 10-Year Follow-Up Study

January 7, 2014

Frances R. Frankenburg, Garrett M. Fitzmaurice, Mary C. Zanarini

Letter to the Editor

Folate Supplementation: Is It Safe and Effective?

May 13, 2009

Frances R. Frankenburg

Original Research

The Association Between Borderline Personality Disorder and Chronic Medical Illnesses, Poor Health-Related Lifestyle Choices, and Costly Forms of Health Care Utilization

December 15, 2004

Frances R. Frankenburg, Mary C. Zanarini

Original Research

A Preliminary, Randomized Trial of Fluoxetine, Olanzapine, and the Olanzapine-Fluoxetine Combination in Women With Borderline Personality Disorder

July 1, 2004

Mary C. Zanarini, Frances R. Frankenburg, Elizabeth A. Parachini

Original Research

Mental Health Service Utilization by Borderline Personality Disorder Patients and Axis II Comparison Subjects Followed Prospectively for 6 Years

January 1, 2004

Mary C. Zanarini, Frances R. Frankenburg, John Hennen, et al

Original Research

Divalproex Sodium Treatment of Women With Borderline Personality Disorder and Bipolar II Disorder: A Double-Blind Placebo-Controlled Pilot Study

May 12, 2002

Frances R. Frankenburg, Mary C. Zanarini

Original Research

Olanzapine Treatment of Female Borderline Personality Disorder Patients: A Double-Blind, Placebo-Controlled Pilot Study

November 1, 2001

Mary C. Zanarini, Frances R. Frankenburg

Letter to the Editor

Cardiorespiratory Problems With Clozapine

November 15, 1996

Frances R. Frankenburg, Douglas Kalunian

Symptomatic Remission and Overall Recovery From BPD

Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time

Smoking in Borderline Patients

Deaths in Borderline Personality Disorder Patients

The Use of Prescription Opioid Medication by Patients With Borderline Personality Disorder and Axis II Comparison Subjects: A 10-Year Follow-Up Study

Folate Supplementation: Is It Safe and Effective?

The Association Between Borderline Personality Disorder and Chronic Medical Illnesses, Poor Health-Related Lifestyle Choices, and Costly Forms of Health Care Utilization

A Preliminary, Randomized Trial of Fluoxetine, Olanzapine, and the Olanzapine-Fluoxetine Combination in Women With Borderline Personality Disorder

Mental Health Service Utilization by Borderline Personality Disorder Patients and Axis II Comparison Subjects Followed Prospectively for 6 Years

Divalproex Sodium Treatment of Women With Borderline Personality Disorder and Bipolar II Disorder: A Double-Blind Placebo-Controlled Pilot Study

Olanzapine Treatment of Female Borderline Personality Disorder Patients: A Double-Blind, Placebo-Controlled Pilot Study

Cardiorespiratory Problems With Clozapine

ELSEWHERE:

FOLLOW US:

Frances R. Frankenburg, MD

Symptomatic Remission and Overall Recovery From BPD

Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time

Smoking in Borderline Patients

Deaths in Borderline Personality Disorder Patients

The Use of Prescription Opioid Medication by Patients With Borderline Personality Disorder and Axis II Comparison Subjects: A 10-Year Follow-Up Study

Folate Supplementation: Is It Safe and Effective?

The Association Between Borderline Personality Disorder and Chronic Medical Illnesses, Poor Health-Related Lifestyle Choices, and Costly Forms of Health Care Utilization

A Preliminary, Randomized Trial of Fluoxetine, Olanzapine, and the Olanzapine-Fluoxetine Combination in Women With Borderline Personality Disorder

Mental Health Service Utilization by Borderline Personality Disorder Patients and Axis II Comparison Subjects Followed Prospectively for 6 Years

Divalproex Sodium Treatment of Women With Borderline Personality Disorder and Bipolar II Disorder: A Double-Blind Placebo-Controlled Pilot Study

Olanzapine Treatment of Female Borderline Personality Disorder Patients: A Double-Blind, Placebo-Controlled Pilot Study

Cardiorespiratory Problems With Clozapine

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles